-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematopoiesis and the Niche

PhD Trainee
Sponsor: Scientific Committee on Hematopoiesis
Program: Scientific Program
Saturday, December 5, 2015: 2:00 PM-3:30 PM
W314, Level 3 (Orange County Convention Center)
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W314, Level 3 (Orange County Convention Center)

Description:

Recent research has capitalized on enhanced imaging modalities, murine modeling, and molecular profiling to afford greater understanding of the hematopoietic stem cell niche. This has led to the concept that hematopoietic niches, whether marrow—based or extramedullary, have crucial roles in regulating the survival, proliferation, and quiescence of hematopoietic stem and progenitor cells with implications not only for normal hematopoiesis but also for malignant hematopoietic states. Discussion of how multiple niche components, both cellular and non-cellular, interact to support normal and malignant hematopoiesis will be the focus of this session.

Dr. Shahin Rafii will focus on the vascular niche contribution to hematopoiesis. He will present insights into how angiocrine factors produced by specialized vascular niches act in paracrine fashion to specify, maintain, and stimulate self-renewal of hematopoietic stem cells.

Dr. Simon Mendez-Ferrer will provide updates on nerve cell and neuroendocrine transmitter regulation of hematopoiesis based on his work regarding autonomic regulation of hematopoiesis as well as neural crest cell contributions to cellular content of the hematopoietic microenvironment.

Dr. David Scadden has pioneered work on osteoblastic niche contributions, differential metabolic dependency of normal and leukemic hematopoiesis and niche competition in hematopoietic malignancies. In this talk, he will focus on how myeloid and lymphoid lineage committed progenitor niches can be defined and how those specialized niches have potential functional impact on hematopoiesis.

Chair:
Jane L. Liesveld, MD, University of Rochester Medical Center

Disclosures:
No relevant conflicts of interest to declare.

Shahin Rafii, MD1,2, Jason M. Butler, PhD3, Ginsberg Michael, PhD2*, Jennifer L Gori, PhD4, Hans-Peter Kiem, MD4 and Scandura Jospeh, MD, PhD5*

1Department of Medicine, Weill Cornell Medical College, New York, NY
2Angiocrine Bioscience, New York, NY
3Ansary Stem Cell Institute, Weill Cornell Medical College, New York, NY
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Weill Cornell Medical College, New York

Simón Méndez-Ferrer, PhD

Stem Cell Institute and Department of Haematology, University of Cambridge and National Health Service Blood and Transplant, Cambridge, United Kingdom

David T. Scadden, MD

Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA

See more of: Scientific Program